Skip to content

Drug interactions

Mifepristone + Upadacitinib

Severity: Moderate

Mifepristone and Upadacitinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Upadacitinib is metabolized mainly by CYP3A4, and strong inhibitors raise its exposure. Mifepristone inhibits CYP3A4, which may increase the risk of infection, cytopenias and other dose-related adverse effects.

What this interaction means in plain words

Mifepristone and Upadacitinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Mifepristone belongs to Endocrine; Upadacitinib belongs to Musculoskeletal.

Evidence level: Moderate

Why it happens

Mifepristone inhibits CYP3A4, reducing upadacitinib clearance.

What to do

Follow upadacitinib labeling for strong CYP3A4 inhibitors, using the lower dose where specified. Monitor for infections and blood count abnormalities.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Mifepristone and Upadacitinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Mifepristone with Upadacitinib?

MediHelp rates the interaction as moderate. Mifepristone and Upadacitinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Upadacitinib is metabolized mainly by CYP3A4, and strong inhibitors raise its exposure. Mifepristone inhibits CYP3A4, which may increase the risk of infection, cytopenias and other dose-related adverse effects.

How serious is the interaction between Mifepristone and Upadacitinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Follow upadacitinib labeling for strong CYP3A4 inhibitors, using the lower dose where specified. Monitor for infections and blood count abnormalities.

What other medicines interact with Mifepristone?

MediHelp also lists interactions of Mifepristone with, for example, Apixaban, Argatroban, Cisapride. The full list is on the Mifepristone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in